AU2002239505A1 - Methods and compositions for the diagnosis and treatment of viral disease using 55092 - Google Patents

Methods and compositions for the diagnosis and treatment of viral disease using 55092

Info

Publication number
AU2002239505A1
AU2002239505A1 AU2002239505A AU3950502A AU2002239505A1 AU 2002239505 A1 AU2002239505 A1 AU 2002239505A1 AU 2002239505 A AU2002239505 A AU 2002239505A AU 3950502 A AU3950502 A AU 3950502A AU 2002239505 A1 AU2002239505 A1 AU 2002239505A1
Authority
AU
Australia
Prior art keywords
diagnosis
compositions
treatment
methods
viral disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239505A
Inventor
William James Cook
Rachel E. Meyers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2002239505A1 publication Critical patent/AU2002239505A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56994Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761Hepatitis B
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
AU2002239505A 2000-12-07 2001-12-06 Methods and compositions for the diagnosis and treatment of viral disease using 55092 Abandoned AU2002239505A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25403700P 2000-12-07 2000-12-07
US60/254,037 2000-12-07
PCT/US2001/046358 WO2002045570A2 (en) 2000-12-07 2001-12-06 Methods and compositions for the diagnosis and treatment of viral disease using 55092

Publications (1)

Publication Number Publication Date
AU2002239505A1 true AU2002239505A1 (en) 2002-06-18

Family

ID=22962691

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239505A Abandoned AU2002239505A1 (en) 2000-12-07 2001-12-06 Methods and compositions for the diagnosis and treatment of viral disease using 55092

Country Status (4)

Country Link
US (1) US20020146686A1 (en)
EP (1) EP1392855A4 (en)
AU (1) AU2002239505A1 (en)
WO (1) WO2002045570A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2709741C2 (en) * 2013-07-30 2019-12-19 ЭсБиАй БАЙОТЕК КО., ЛТД. Medicinal agent containing phospholipase d4 antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1632499E (en) * 1999-03-08 2007-09-11 Genentech Inc Gene sequences amplified in tumours and their diagnostic uses
US20030124575A1 (en) * 2000-03-29 2003-07-03 Gudrun Werner Organic compounds

Also Published As

Publication number Publication date
WO2002045570A2 (en) 2002-06-13
WO2002045570A9 (en) 2002-10-24
EP1392855A2 (en) 2004-03-03
EP1392855A4 (en) 2005-05-25
WO2002045570A3 (en) 2003-01-23
US20020146686A1 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001278852A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU2001249329A1 (en) Lipoxin analogs and methods for the treatment of periodontal disease
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU2002239505A1 (en) Methods and compositions for the diagnosis and treatment of viral disease using 55092
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2002348324A1 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 46566
AU2002232433A1 (en) Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3
AU2001241778A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular, hepatic, and bone disease